Shiu‐Feng Huang
National Health Research Institutes(TW)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)1,584 cited
- → High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan(2004)551 cited
- → Novel Prognostic Value of Nuclear Epidermal Growth Factor Receptor in Breast Cancer(2005)289 cited
- → Type II Collagen Gene Variants and Inherited Osteonecrosis of the Femoral Head(2005)187 cited
- → A Cullin3-KLHL20 Ubiquitin Ligase-Dependent Pathway Targets PML to Potentiate HIF-1 Signaling and Prostate Cancer Progression(2011)180 cited
- → Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways(2003)167 cited
- → Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma(2021)145 cited
- → Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia(1998)133 cited
- → Upregulation of SOX9 in Lung Adenocarcinoma and Its Involvement in the Regulation of Cell Growth and Tumorigenicity(2010)122 cited
- → Stathmin1 overexpression associated with polyploidy, tumor‐cell invasion, early recurrence, and poor prognosis in human hepatoma(2010)120 cited